SavedAdd your journal

Journals / Endokrinolojide Yönelişler / 2002 / Cilt: 11 - Sayı: 4

Increased prevalance of HCV infection in patients with type 2 diabetes mellitus

Tip 2 diabetik hastalarda artmış HCV infeksiyonu sıklığı

Bahadır CEYLAN
Kağan GÜNGÖR
Ali MERT
Pages
155–156
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Anti-HCV positivity of type 2 DM patients was found higher than blood donors (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In literature, increased prevalance of hepatitis C virus (HCV) infection in type 2 diabetes mellitus(DM) patients has recently been reported.
📊
Key Findings & Data:We aimed to investigate HCV infection prevalance in type 2 DM patients. 60 type 2 DM patients (44 female, 16 male, mean age: 55, range: 40-86) were enrolled in the study.
💡
Conclusion & Impact:Anti-HCV positivity of type 2 DM patients was found higher than blood donors (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In literature, increased prevalance of hepatitis C virus (HCV) infection in type 2 diabetes mellitus(DM) patients has recently been reported. We aimed to investigate HCV infection prevalance in type 2 DM patients. 60 type 2 DM patients (44 female, 16 male, mean age: 55, range: 40-86) were enrolled in the study. In these patients, anti-HCV an-tibodies and HBsAg positivity were investigated by ELISA. As a control group, blood donors were used. Chi-square test was used for statistical analysis. In type 2 DM patients, anti-HCV antibodies and HBsAg positivity were founded as 12% (7/60) and 7% (4/60), respectively. In blood donors , anti-HCV antibodies and HbsAg positivity were found as 0,8% (104/12513) and 4% (567/14317), respectively. Anti-HCV positivity of type 2 DM patients was found higher than blood donors (p

Özet

Tip 2 diabetes mellituslu (DM) hastalarda artmış hepatit C virüs (HCV) enfeksiyonu sıklığı literatürde bildirilmeye başlanmıştır. Biz de kendi tip 2 DM hastalarımızda HCV enfeksiyonu sıklığını araştırdık. Çalışmaya tip 2 DM olan 60 hasta ( 44 kadın, 16 erkek, ortalama yaş: 55, yaş aralığı: 40-86) alındı.Hastalarda anti-HCV antikoru ve HBsAg pozitifliği ELISA yöntemi ile araştırıldı. Kontrol grubu olarak hastanemiz kan merkezi donörleri kullanıldı. İstatistiksel değerlendirmede ki-kare testi kullanıldı. Çalışmamızda olguların %12'sinde (7/60) anti-HCV antikoru , %7'sinde ise (4/60) HBsAg pozitifliği saptandı. Kan merkezi dönerlerinde anti-HCV antikoru %0,8 (104/ 12513) ve HBsAg pozitifliği %4 (567/14317) bulundu. Anti-HCV pozitifliği diabetiklerde oldukça yüksek bulunurken (p=0,0001) HBsAg sıklığı donörlerden istatistiksel olarak farklı bulunmadı. Sonuç olarak Tip 2 diabetes mellitus hastalarında HCV enfeksiyonu sıklığı artmış olarak bulunmuştur. Bu nedenle HCV enfeksiyonu ile Tip 2 diabetes mellitus arasında bir ilişki olduğu düşünülebilir.

🔖

Cite This Article

CEYLAN, B., GÜNGÖR, K., MERT, A. (2022). Increased prevalance of HCV infection in patients with type 2 diabetes mellitus. Endokrinolojide Yönelişler, Cilt: 11 - Sayı: 4, 155–156. https://ajindex.com/articles/500943

References (14)

  1. Allison ME, Wreghhitt T, Palmer CR, Alexander GJ. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994;21:1135-9
  2. Mason AL, Lau JY, Hoang N, Qian K, Alexander GJ, Xu L, Guo L, et al. Association of diabetes mellitus and chronic hepatitis C virus in¬ fection. Hepatology 1999;29:328-33
  3. Fraser GM, Harman I, Meller N, Niv Y, Porath A. Diabetes mellitus is associated with chronic hepatitis C but not chronic hepatitis B infec¬ tion. Isr J Med Sci 1996;32:526-30
  4. Caronia S, Taylor K, Pagliaro L, Carr C, Palazzo U, Petrik J, et al. Furt¬her evidence for an association between non-insulin-dependent di¬ abetes mellitus and chronic hepatitis C virus infection. Hepatology 1999;30:1059-63
  5. Gowans EJ. Distribution of markers of hepatitis C virus infection thro¬ ughout the body. Semin Liver Dis 2000;20:85-102
  6. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Tho¬ mas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000; 133:592-9
  7. Simo R, Hernandez C, Genesca J, Jardy R, Mesa J. High prevalence of hepatitis C virus infection in diabetic patient; Diabetes Care 1996; 19:998-1000
  8. Konrad T, Zeuzem S, Vicini P, Toffolo G, Briem D, Lormann J, et al. Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon-a. Eur J Clin Invest 2000;30:lll-21
  9. Sheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko G. The pathology of hepatitis C. Hepatology 1992;15:567-71
  10. Moria K, Yotsuyanagi H, Shintani Y, Fujie H, İshibashi K, Matsuura Y, et al. Hepatitis C virus core protein induces hepatic steatosis in trans- genic mice. J Gen Virol 1997;78:1527-31
  11. Wong VS, Wight DG, Palmer CR, Alexander GJ. Fibrosis and other histological features in chronic hepatitis C virus infection: A statisti¬ cal model. J Clin Pathol 1996;49:465-9
  12. Hourigan IF, Macdonald GA, Purdie D, Whithall VH, Shorthouse C, Clouston A, et al. Fibrosis in chronic hepatitis C corelates significantly with body mass index and steatosis. Hepatology 1999; 29:1215-9
  13. Fujie H, Yotsuyanagi H, Moriya K, Shintani Y, Tsutsumi T, Takayama T, et al. Steatosis and intahepatic hepatitis C virus in chronic hepati¬ tis. J Med Virol 1999;59:l4l-5
  14. National Center for Health Statistics. Plan and Operation of the Third National Health and Nutrition Examination Survey, 1